SEPARATION/CONSULTING AGREEMENTSeparation/Consulting Agreement • July 3rd, 2024 • Ashford Hospitality Trust Inc • Real estate investment trusts
THIS SEPARATION/CONSULTING AGREEMENT (this “Agreement”) is made as of June 30, 2024, by and among J. ROBISON HAYS, III (the “Executive”), ASHFORD HOSPITALITY ADVISORS LLC (the “Company”), and ASHFORD INC. (“AINC,” together with the Executive and the Company, the “Parties”). All capitalized terms not defined in this Agreement shall have the meanings assigned to such terms in that certain Second Amended and Restated Employment Agreement among the Parties dated as of January 4, 2021 (the “Employment Agreement”).
GENERAL RELEASE AND POST-SEPARATION CONSULTING AGREEMENTSeparation Consulting Agreement • January 4th, 2016 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This General Release and Post-Separation Consulting Agreement (the “Agreement”) is made and entered into by and between Arlene Morris (the “Executive”) and Syndax Pharmaceuticals, Inc. (the “Company”) (each a “Party,” and together, the “Parties”).
SEPARATION/CONSULTING AGREEMENTSeparation/Consulting Agreement • August 8th, 2006 • Ev3 Inc. • Surgical & medical instruments & apparatus • Minnesota
This Separation/Consulting Agreement (“Agreement”) is made and entered into by and between Thomas Wilder, whose address is 1841 Port Sheffield Place, Newport Beach, CA 92660 (“Employee”) and ev3 Inc., whose address is 9600 54th Avenue North, Plymouth, MN 55442 (“Employer”).
CONFIDENTIAL SEPARATION, GENERAL RELEASE AND POST-SEPARATION CONSULTING AGREEMENTSeparation Consulting Agreement • March 13th, 2024 • Nextnav Inc. • Search, detection, navagation, guidance, aeronautical sys
This Confidential Separation, General Release and Post-Separation Consulting Agreement (the “Agreement”) is being entered into between Ganesh M. Pattabiraman (“Executive”), on the one hand, and NextNav, Inc., NextNav, LLC, and an directly, wholly-owned subsidiary of NextNav, Inc. (collectively, the “Company”), on the other hand, in connection with the termination of Executive’s employment with the Company on November 29, 2023 (the “Separation Date”). Executive and the Company are referred to collectively as the “Parties.”
GENERAL RELEASE AND POST-SEPARATION CONSULTING AGREEMENTSeparation Consulting Agreement • November 6th, 2014 • Hyperion Therapeutics Inc • Pharmaceutical preparations
This General Release and Post-Separation Consulting Agreement (the “Agreement”) is made and entered into by and between Klara A. Dickinson-Eason (the “Executive”) and Hyperion Therapeutics, Inc. (the “Company”) (each a “Party,” and together, the “Parties”).
